🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
1,179

Quick answer

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ramelteon

    Takeda

    Migraine Headache

    approved small molecule terminated

    1 trial

  2. rhPTH (1-84)

    Takeda

    Hypoparathyroidism

    approved mab completed

    3 trials

  3. rhPTH(1-84)

    Takeda

    Chronic Hypoparathyroidism

    approved small molecule terminated

    2 trials

  4. rt-PA

    Takeda

    Lacunar Stroke

    approved small molecule active

    1 trial

  5. theophylline

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  6. vortioxetine

    Takeda

    Depression

    approved small molecule completed

    1 trial

  7. Azilsartan medoximil

    Takeda

    Hypertension

    small molecule completed

    1 trial

  8. Colonoscopy

    Takeda

    CD

    other active

    2 trials

  9. Dexlansoprazole

    Takeda

    Laryngo-pharyngeal Reflux

    small molecule terminated

    1 trial

  10. Febuxostat

    Takeda

    Chronic Kidney Disease

    small molecule completed

    1 trial

  11. Glimepiride

    Takeda

    Type 2 Diabetes

    small molecule active

    1 trial

  12. Gluten

    Takeda

    Celiac Disease

    other completed

    1 trial

  13. Lubiprostone

    Takeda

    Constipation-predominant Irritable Bowel Syndrome

    small molecule completed

    1 trial

  14. Lubiprostone

    Takeda

    Diabetes Mellitus, Type 1

    small molecule terminated

    1 trial

  15. Phentermine

    Takeda

    Obesity

    small molecule completed

    1 trial

  16. Pioglitazone

    Takeda

    Uric Acid Kidney Stone Disease

    small molecule completed

    1 trial

  17. Pioglitazone

    Takeda

    HIV Infections

    small molecule completed

    1 trial

  18. Placebo and Escitalopram

    Takeda

    Panic Disorder

    small molecule terminated

    1 trial

  19. RNAseq

    Takeda

    Non-small Cell Lung Cancer

    gene therapy active

    1 trial

  20. Ramelteon

    Takeda

    Healthy

    small molecule completed

    1 trial

  21. Ramelteon

    Takeda

    Neuropathic Pain

    small molecule terminated

    1 trial

  22. Rozerem

    Takeda

    REM Behavior Disorder

    small molecule terminated

    1 trial

  23. Steroid and Proton Pump Inhibitor Therapy

    Takeda

    Suspected Eosinophilic Esophagitis

    small molecule completed

    1 trial

  24. Technochrom C1-INH Kit

    Takeda

    Hereditary Angioedema (HAE)

    other active

    1 trial

  25. UMULINE NPH

    Takeda

    Type 2 Diabetes

    small molecule terminated

    1 trial

  26. blood sampling (alpha-Galactosidase & LysoGb3)

    Takeda

    Fabry Disease

    other active

    1 trial

  27. lubiprostone

    Takeda

    Bowel Preparation for Colonoscopy

    small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.